• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

FDA recalls Philips CT scanner

Article

The Food and Drug Administration has recalled 15 Philips Medical Systems Tomoscan SR4000 CT scanners because of a defect that shows up when an image is reversed in the system’s databank, according to an FDA enforcement report. The defect in the

The Food and Drug Administration has recalled 15 Philips Medical Systems Tomoscan SR4000 CT scanners because of a defect that shows up when an image is reversed in the system’s databank, according to an FDA enforcement report. The defect in the system causes a patient’s image to be reversed left to right when a clinician retrieves it.

The problem was found during a routine FDA inspection several months ago, a Philips official said. He said the company hasn’t received any complaints from customers.

“There has to be a very specific set of circumstances for (the defect) to happen,” the Philips official said. “We have identified it as possible, and we are taking steps to correct the information.”

Related Videos
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.